Steven Schain, Author at Cannabis Business Executive - Cannabis and Marijuana industry news

How Cannabis Got Fat and Sassy With a Little Help From Alaska

By Steven Schain Butters, oils and fats are essential building blocks of cannabis-infused foods and beverages, the fastest growing segment of the legalized marijuana market that generated $30 billion in 2022 domestic revenue. The world of cannabis edibles just exploded…

Tools to Keep Cannabis Companies From Crashing in Oversaturated Markets

By Steven Schain Facing rising interest rates making capital even pricier, coupled with a highly saturated market competing for a limited customer base beset by plummeting prices and diminishing profit margins, it’s unclear whether Skymint will be liquidated or reorganized…

Cannabis’ Plummeting Price-Per-Pound and the Rise of Delta-8 THC

December 12, 2022
Steven Schain
Hemp Business Executive, News & Insights
0 Comments

Although forming America’s sixth-largest crop yielding 48.8 million pounds of flower and $27 billion in legal sales annually, marijuana’s plunging price-per-pound and the availability of cheaper, unregulated hemp-derived tetrahydrocannabinol (THC) products is thwarting the cannabis industry. Whether cultivated indoors, outdoors…

How Cannabis is Conquering NFTs and The Metaverse

November 7, 2022
Steven Schain
Marketing
0 Comments

By Steven Schain Imagine selling a product subject to 38 conflicting sets of labelling and marketing regulations that can neither cross state lines nor be purchased with a credit card. Now envision a global marketplace platform free of “transportation, purchase…

Are All “Cannabis Appellations” Malarkey?

To differentiate superior product, command higher prices, and create regional unity, California launched a Marijuana “appellation of origin” program validating sun-grown Cannabis’ geographical origin and production methods with a protective designation. While aspiring to mirror its wine industry counterparts’ success and…

Valuing That Golden Ticket: What’s a Marijuana License Actually Worth?

Building a cannabis enterprise requires staggering and constant fundraising and, because of the industry’s dynamic nature, any given license’s value is subjective, fluctuates with external factors beyond the licensee’s control, and may change by the minute. Contrary to popular myth,…

FDA Tackles “Cannabis-Derived Products”

March 21, 2022
Steven Schain
Federal
0 Comments

If you can’t measure it, you can’t manage it! With Cannabis-Derived Products (“CDPs”) outpacing the existing science and imposing massive health concerns, in October 2021 the U.S. Food and Drug Administration (“FDA”) issued a “Cannabis-Derived Products Data Acceleration Plan” (“CDP…

Why the SAFE Banking Act Stinks for MRBs

Despite lessening criminal/administrative penalties and depository insurance obstacles, the SAFE Banking Act fails to put legal cannabis on equal footing with all other legitimate industries or make depository accounts and merchant services either available or affordable. Heralded by the cannabis…

Obtaining IP Protection for Cannabis Consumer Packaged Goods

How do you protect intellectual property rights in an insanely lucrative, nearly legal ingredient poised to detonate the consumer packaged goods (CPGs) industry? While the Wall Street Journal reports that cannabis 2020’s domestic sales exceeded $20 billion, and despite being…

How Delta-8 Hemp Sucker Punched Legalized Marijuana

Mirroring legalized marijuana’s tetrahydrocannabinol (Delta-9 THC) effects, hemp derived tetrahydrocannabinol (Delta-8 THC) requires no license, is readily available online and over-the-counter, and is cutting into legalized cannabis’ $20 billion-plus annual revenue. It gets you high, it’s cheaper than cannabis, and…

Data-Breach Concerns Rise As New York Launches Adult-Use Cannabis Program

Becoming the 17thstate to legalize Adult-Use Cannabis, on March 31, 2021, New York enacted the “Marijuana Regulation and Taxation Act” (“MRTA”) anticipated to generate $1.2 billion in annual sales by 2023. Because of the sensitive and protected health information that…

Jersey Clobbers “Cannabis Licensing Lawsuits” and launches Triumphant Adult Use Program

With the Eastern seaboard’s most ambitious Adult Use program primed to explode, New Jersey’s Superior Court Appellate Division (“Appellate Division”) just lifted its “stay” on scoring 18 month old Medical Marijuanaapplications clearing the way for 5 cultivation, 15 dispensary, and…

Why Cannabis Is Shut Out of $900 Billion Economic Aid Act

In tranches of up to $10 million, the federal government is doling out $900 billion of forgivable loans to borrowers other than “plant touching” marijuana-related businesses (MRBs). By Steve Schain In tranches of up to $10 million, the federal government is…

Why Jersey’s Adult Use Program Will Ignite East Coast Cannabis

December 16, 2020
Steven Schain
New Jersey
0 Comments

With 44 million consumers banging on its door, and $950 million of revenue projected over the next three years, New Jersey’s adult use marijuana program is poised to define cannabis across the eastern seaboard. With 44 million consumers banging on…

Why Explosive Applications Create Bulletproof Marijuana Businesses

November 4, 2020
Steven Schain
Best Practices, Compliance and Regulations, Policy & Legal
0 Comments

In 2019, legalized Marijuana’s domestic sales reached $11.7 billion, and grow, processing and dispensary licenses were valued at (and, reportedly, sold for) over $20 million dollars. Licenses are granted by the respective 33 states with Marijuana programs, most of which impose…